Literature DB >> 13627753

Myleran therapy in bronchogenic carcinoma.

R D SULLIVAN.   

Abstract

Entities:  

Keywords:  BUSULFAN/therapeutic use; LUNG NEOPLASMS/therapy

Mesh：

Substances：

Year:  1958        PMID： 13627753     DOI： 10.1111/j.1749-6632.1958.tb42662.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  2 in total

1.  Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations.

Authors:  I Boland; G Vassal; J Morizet; M J Terrier-Lacombe; D Valteau-Couanet; C Kalifa; O Hartmann; A Gouyette
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

2.  Fifteen-year follow-up of all patients in a study of post-operative chemotherapy for bronchial carcinoma.

Authors:  D J Girling; H Stott; R J Stephens; W Fox
Journal:  Br J Cancer       Date:  1985-12       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.